What decides about cardiac complications in patients with type 2 diabetes mellitus and silent myocardial ischaemia - Five-year follow-up;Co decyduje o wystȩpowaniu powikłań kardiologicznych u osób z cukrzyca̧ typu 2 i niemym niedokrwieniem? Piȩcioletnia obserwacja

Polskie Archiwum Medycyny Wewnetrznej

Volumn 112, Issue 6, 2004, Pages 1433-1443

  Mamcarz, Artur ^a,b   Chmielewski, Marek ^a   Braksator, Wojciech ^a   Syska Sumińska, Joanna ^a   Janiszewski, Maciej ^a   Król, Jarosław ^a   Kuch, Marek ^a   Kuch, Jerzy ^a   Dłuzniewski, Mirosław ^a  

^a II Kat I Klinika Kardiologii W   (Poland)

^b NONE   (Poland)

Author keywords

Complications; Non insulin dependent diabetes mellitus (type 2 DM); Silent myocardial ischemia

Indexed keywords

GLUCOSE; INSULIN; ORAL ANTIDIABETIC AGENT;

ADULT; ANAMNESIS; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL EXAMINATION; CONTROLLED STUDY; CORONARY RISK; DIABETES CONTROL; DISEASE DURATION; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; FOLLOW UP; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; ISCHEMIA; LABORATORY TEST; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PHYSICAL EXAMINATION; PREVALENCE; SILENT MYOCARDIAL ISCHEMIA; SUDDEN DEATH; UNSTABLE ANGINA PECTORIS; AGED; CASE CONTROL STUDY; CONFIDENCE INTERVAL; CONGESTIVE HEART FAILURE; ELECTROCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE ISCHEMIA; MIDDLE AGED; PATHOPHYSIOLOGY; POLAND; RISK; RISK ASSESSMENT; TIME;

ADULT; AGED; ANGINA, UNSTABLE; CASE-CONTROL STUDIES; CONFIDENCE INTERVALS; DIABETES MELLITUS, TYPE 2; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; ODDS RATIO; POLAND; PREVALENCE; RISK ASSESSMENT; TIME FACTORS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 15244351434     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Tatoń J., Szczeklik-Kumala Z., Czech A.: Ostry zawał serca u osób z cukrzyca̧: Odrȩbności epidemiologiczne, diagnostyczne, i terapeutyczne. Medipress Kardiologia, 2001, 8, 21.
2. Mamcarz A., Braksator W., Światowiec A. i wsp.: Zaburzenia funkcji skurczowej i rozkurczowej lewej komory u chorych z cukrzya̧ i niemym niedokrwieniem. Polski Przegl. Kardiol., 2003, 5, 25.
3. Mamcarz A., Światowiec A., Syska-Sumićska J. i wsp.: Nieme niedokrwienie pogarsza tolerancjȩ wysiłku u chorych z cukrzya̧. Obserwacja wieloletnia. Polski Przegla̧d Kardiologiczny, 2003, 5, 139.
4. Zimmet P.: Wzrastaja̧ca czȩstość cukrzycy typu 2: Rozwój epidemii w perspektywie ogólnoświatowej. medicographia, 2000, 12, 8.
5. Lakka i H.M., Laaksonen D.E., Lakka T.A. i wsp.: The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA, 2002, 2882, 709.
6. Haffner S.M.: Mortality from coronary heart disease in subjects with type 2 diabetes and in non-diabetic subjects with and without prior MI. N. Engl. J. Med., 1998, 339, 229.
7. Hasdai D., Granger C.B., Srivatsa S.S. i wsp.: Diabetes mellitus and outcome after primary coronary angioplasty for acute myocardial infarction: lessons from the GUSTO IIb Angioplasty Substudy. J. Am. Coll. Cardiol., 2000, 35, 1502.
8. Airaskinen K., Koistinen M.: Association between silent coronary artery disease, diabetes and autonomic neuropathy. Fact or fallacy? Diabetes Care, 1992, 15, 288.
9. Mamcarz A.: Nieme niedokrwienie u chorych z cukrzyca̧ insulinoniezależna̧ - czȩstość wystȩpowania, uwarunkowania kliniczne i metaboliczne. Polski Przegla̧d Kardiologiczny, 2001, 3, 297.
10. ACC/AHA Guidelines for exercise testing. A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on Exercise Testing). J. Am. Coll. Cardiol., 1997, 30, 260.
11. ACC/AHA Guidelines for the Clinical Application of Echocardiography: executive summary. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committe on Clinical Application of Echocardiography). J. Am. Coll. Cardiol., 1997, 29, 862.
12. Stern S., Tzivoni D.: Early detection of ischaemic heart disease by 24-hour electrocardiographic monitoring of active subjects. Br. Heart J., 1974, 36, 481.
13. Kannel W.B., Mc Gee D.L.: Diabetes and cardiovascular risk factors: The Framingham study. Circulation, 1979, 59, 8.
14. Leyden E.: Asthma and diabetes mellitus. Z. Klin. Med., 1981, 3, 358.
15. Rubler S., Dlugash J., Yuceoglu Y.Z. i wsp.: New type of cadiomyopathy associated with diabetic glomerulosclerosis. Am. J. Cardiol., 1972, 30, 595.
16. Sironi A.M., Ferrannini E.: Patofizjologia niewydolności serca u chorych na cukrzycȩ. Medicograpia, 1998, 8, 45.
17. Poirier P., Bogaty P., Garneau C. i wsp.: Diastolic dysfunction in normotensive men with well-controlled type 2 diabetes: importance of maneuvers in echocardiographic screening for preclinical diabetic cardiomyopathy. Diabetes Care, 2001, 24, 5.
18. Zarich S.W., Nesto R.W.: Diabetes cardiomyopathy. Am. Heart J., 1989, 118, 1000.
19. Delenne J., Savin B., Bory M. i wsp.: Silent myocardial ischemia in patients with diabetes: who to screen? Diabetes Care, 1999, 22, 1396.
20. MiSAD Group: Prevalence of unrecognised silent myocardial ischemia and its association with atherosclerosis risk factors in non-insulin-dependent diabetes mellitus. Milan Study on Atherosclerosis and Diabetes. Am. J. Cardiol., 1997, 792, 134.
21. Camp A.D., Garvin P.J., Hoff J.J. i wsp.: Prognostic value of intravenous dipirydamole thallium imaging in patients with diabetes mellitus considered for renal transplantation. Am. J. Cardiol., 1990, 65, 1459.
22. Bech J., Pedersen F.H., Madsen B.K. i wsp.: Changes in left ventricular ejection fraction during transient myocardial ischemia in patients with angina pectoris and silent ischemia. Dan. Med. Bull., 1994, 41, 231.
23. Elhendy A., Geleijnse M.L., Roelandt J.R. i wsp.: Stress-induced ventricular dysfunction in silent and syptomatic myocardial ischemia during dobutamine stress test. Am. J. Cardiol., 1995, 75, 1112.
24. Coisne D., Donal E., Torremocha F. i wsp.: Dobutamine stress echocardiography response of asymptomatic patients with diabetes. Echocardiography, 2001, 18, 373.
25. Grundy S.M., Benjamin L.J., Burke G.L.: Cukrzyca a choroby układu sercowo-naczyniowego. Raport Amerykańskiego Towarzysta Kardiologicznego skierowany do służby zdrowia. Czynniki Ryzyka, 1999, 2, 44.
26. Balkau B.: Wieńcowe powikłania cukrzycy: spojrzenie epidemiologa. Medicograpia, 1998, 8, 6.
27. Jȩdrzejowska H.: Neuropatia obwodowego układu nerwowego. [w:] Powikłania cukrzycy. (red.) J. Tatoń, PZWL, Warszawa 1995, 319.
28. Low P.A., Tuck R.R., Takeucki M.: Nerve microenvironment in diabetic neuropathy. Diabetic neuropathy. (red.) Dyck P.W.B. Saunders Co, Philadephia 1987.
29. Fagerberg S.E.: Diabetic neuropathy: a clinical and histological study on the significance of vascular affections. Acta Med. Scand., 1959, 345, 1.
30. The Diabetes Control and Complication Trial (DCCT) Research Group. Effect of intensive diabetes management on macrovascular events and risk factors in the Diabetic Control and Complication Trial. Am. J. Cardiol., 1995, 75, 894.
31. Tatoń J.: Powikłania cukrzycy. PZWL, Warszawa 1995.
32. The University Group Diabetes Program. A study of the effects of hypoglycaemic agents on vascular complications in patients with adult-onset diabetes II. Mortality results. Diabetes, 1970, 19, 789.
33. Kuusisto J., Mykkanen L., Pyorala K. i wsp.: NIDDM and its metabolic control predict coronary heart disease in elderly subjects. Diabetes, 1994, 43, 960.
34. Pontiroli A.E., Pacchioni M., Camisasca R. i wsp.: Markers of insulin resistance are associated with cardiovascular morbidity and predict overall mortality in long-standing non-insulin dependent diabetes mellitus. Acta Diabetol., 1998, 35, 32.
35. Hume L., Oakley G., Boulton A. i wsp.: Ambulatory monitoring of the ST - segment in diabetic men with and without peripheral neuropathy. Diabetes Med., 1989, 3, 545.
36. Nesto R.W., Kett K.J.: Silent myocardial ischemia in the diabetic patient. [w:] Silent Myocardial Ischemia and Angina, Prevalence, Prognostic and Therapetuc Significance. Pergamon Press, 1998, 126.